Literature DB >> 4117436

Gestronol hexanoate (SH582) and benign prostatic hypertrophy.

A G Pitchford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4117436      PMCID： PMC1644142     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  6 in total

1.  INSECT-STING ALLERGY: QUESTIONNAIRE STUDY OF 2,606 CASES.

Authors:  J P LOGE
Journal:  JAMA       Date:  1965-07-12       Impact factor: 56.272

2.  The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy.

Authors:  D A Aubrey; T Khosla
Journal:  Br J Surg       Date:  1971-09       Impact factor: 6.939

3.  [Treatment of prostatic hypertrophy with depostat].

Authors:  M Nuri; K Hochberg
Journal:  Munch Med Wochenschr       Date:  1970-05-29

4.  [Treatment of hypertrophy of the prostate with gestagens].

Authors:  W Vahlensieck; S Gödde
Journal:  Munch Med Wochenschr       Date:  1968-06-28

5.  The effect of depostat (SH 582) on the baboon prostate.

Authors:  R Schoonees; J N de Klerk; G P Murphy
Journal:  J Surg Oncol       Date:  1969       Impact factor: 3.454

6.  [Animal experimental studies using 19-nor-17 alpha-hydroxyprogesterone caproate (Gestenoroncapronat) with respect to a possible therapeutic application in prostatic adenoma].

Authors:  J D Hahn; F Neumann; R Berswordt-Wallrabe
Journal:  Urologe       Date:  1968 Jul-Aug       Impact factor: 0.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.